相关实验视频
Updated: Jan 17, 2026

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
19.8K
皮质类固醇治疗在类固醇治疗中的安全性
Alessandro Di Marco Berardino1, Federico Mei2, Lina Zuccatosta1
1Respiratory Diseases Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Frontiers in drug safety and regulation
|September 22, 2025
概括
系统性皮质糖类固醇是沙尔科毒症的首要治疗方法,尽管有潜在的不良影响. 仔细监测剂量和持续时间对于管理这种多系统性颗粒性疾病至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
背景情况:
- 沙丘病是一个多系统的颗粒性疾病,病因不明.
- 临床表现因受影响的器官而异,胸部参与是最常见的.
- 非化颗粒瘤是他的病理学标志.
研究的目的:
- 为了提供一个全面的关于糖皮质激素治疗在肉类发病中的安全性概况的综述.
- 讨论与皮质类固醇治疗相关的全身影响和潜在不良事件.
- 更新临床医生关于管理糖皮质类药物在肉类发病患者的使用情况.
主要方法:
- 一个叙事文学的评论.
- 我们搜索了四个电子数据库 (PubMed,Cochrane,Scopus,Ovid Medline) 和谷歌.
- 包括在2023年2月之前发表的关于沙尔科病的皮质类固醇不良事件的研究,元分析和评论.
主要成果:
- 系统性葡萄糖皮质类药物是传统的型硬化症的第一线治疗方法.
- 长期使用皮质类固醇可以导致广泛的并发症.
- 对于耐火性病例,存在替代疗法,如甲醇.
结论:
- 皮质类固醇仍然是类固醇症的首选治疗方法.
- 精心调整和监测葡萄糖皮质激素剂量和持续时间至关重要.
- 平衡有效性与潜在的不良影响是沙尔科毒症管理的关键.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
COPD: Management Using Bronchodilators and Corticosteroids
737
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
737
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Pericarditis III: Medical Management
313
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
313
Pulmonary Tuberculosis I
844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844

